MedPath
TGA Approval

Desferoxamine Mesylate For Injection 2 g per vial (315120)

315120

Desferoxamine Mesylate For Injection 2 g per vial

Hospira Australia Pty Ltd

March 6, 2019

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

desferrioxamine mesilate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.